Clinical Trial Update: Troponin to Detect Major Cardiovasculaire Advserse Events on Immune Checkpoint Inhibitors

View source ↗

Summary

This completed clinical trial investigated whether troponin testing could detect major cardiovascular adverse events in patients treated with immune checkpoint …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cardiovascular Disease

Drugs mentioned

• Immune checkpoint inhibitors (class)

Snippet

Sponsor: Institut Mutualiste Montsouris | Conditions: Cancer, Immune Checkpoint Inhibitor | Status: COMPLETED